Home
NKGN
NKGN News

Latest NKGen Biotech Inc. (NKGN) News on November 22, 2024

NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

GlobeNewswire

24 days ago

NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)

GlobeNewswire

a month ago

NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)

NKGen Biotech Announces Poster Presentations at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

GlobeNewswire

a month ago

NKGen Biotech Announces Poster Presentations at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

NKGen Biotech’s Positive Phase 1 Clinical Data in Moderate Alzheimer’s Disease Advances Troculeucel into Phase 2 with First Patient Dosed in Phase 1/2a Trial

GlobeNewswire

2 months ago

NKGen Biotech’s Positive Phase 1 Clinical Data in Moderate Alzheimer’s Disease Advances Troculeucel into Phase 2 with First Patient Dosed in Phase 1/2a Trial

NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

3 months ago

NKGen Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report

GlobeNewswire

3 months ago

NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report

NKGen Biotech Presents New Positive SNK01 Biomarker Data at the 2024 Alzheimer’s Association International Conference

GlobeNewswire

4 months ago

NKGen Biotech Presents New Positive SNK01 Biomarker Data at the 2024 Alzheimer’s Association International Conference

NKGen Biotech to Present New Positive SNK01 Clinical Trial Biomarker Data at the 2024 Alzheimer’s Association International Conference

GlobeNewswire

4 months ago

NKGen Biotech to Present New Positive SNK01 Clinical Trial Biomarker Data at the 2024 Alzheimer’s Association International Conference

NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors

GlobeNewswire

4 months ago

NKGen Biotech Appoints Dr. Marco Gottardis to its Board of Directors

NKGen Biotech Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024

GlobeNewswire

5 months ago

NKGen Biotech Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024

NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024

GlobeNewswire

6 months ago

NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024

NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

6 months ago

NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Disease

GlobeNewswire

6 months ago

NKGen Biotech’s SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer’s Disease

NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition

GlobeNewswire

6 months ago

NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition

NKGen Biotech Announces FDA Clearance of Investigational New Drug (IND) Application for SNK01 NK Cell Therapy in Parkinson’s Disease

GlobeNewswire

7 months ago

NKGen Biotech Announces FDA Clearance of Investigational New Drug (IND) Application for SNK01 NK Cell Therapy in Parkinson’s Disease

NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

GlobeNewswire

7 months ago

NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

7 months ago

NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

GlobeNewswire

7 months ago

NKGen Biotech Announces Upcoming Presentation on SNK01 NK Cell Therapy in Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit

NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs

GlobeNewswire

7 months ago

NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs

NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer’s Disease at the Tau2024 Global Conference

GlobeNewswire

8 months ago

NKGen Biotech Presents Additional Phase 1 Clinical Trial Data in Alzheimer’s Disease at the Tau2024 Global Conference

NKGen Biotech Announces Upcoming Presentation on SNK01 in Alzheimer’s Disease at the Tau2024 Global Conference

GlobeNewswire

9 months ago

NKGen Biotech Announces Upcoming Presentation on SNK01 in Alzheimer’s Disease at the Tau2024 Global Conference

Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies

News Direct

9 months ago

Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies

First National Corporation Reports Annual and Fourth Quarter 2023 Financial Results

GlobeNewswire

10 months ago

First National Corporation Reports Annual and Fourth Quarter 2023 Financial Results

Business Wire

10 months ago

Babcock & Wilcox Awarded Utility-Scale Solar EPC Contracts Totaling 75 Megawatts in Pennsylvania

Associated Press Finance

10 months ago

First Internet: Q4 Earnings Snapshot

The Joint Chiropractic Named No. 1 in Chiropractic Services, Ranked Among Top Franchises in Entrepreneur Magazine's Franchise 500

PR Newswire

10 months ago

The Joint Chiropractic Named No. 1 in Chiropractic Services, Ranked Among Top Franchises in Entrepreneur Magazine's Franchise 500

Business Wire

10 months ago

Babcock & Wilcox and Black Hills Energy Receive State of Wyoming Grant to Develop a Low-Carbon Hydrogen Facility Using BrightLoop™ Technology

GlobeNewswire

10 months ago

Comscore and Nexstar Reach Multi-Year Agreement for Linear and Cross-Platform Audience Measurement

Lenders One Welcomes 29 New Member Companies to the Cooperative

GlobeNewswire

10 months ago

Lenders One Welcomes 29 New Member Companies to the Cooperative

Business Wire

10 months ago

Babcock & Wilcox Enterprises Announces New $150 Million Senior Secured Credit Facility; Reaffirmed Credit Rating of BB+

Here's Why We're A Bit Worried About FTC Solar's (NASDAQ:FTCI) Cash Burn Situation

Simply Wall St.

10 months ago

Here's Why We're A Bit Worried About FTC Solar's (NASDAQ:FTCI) Cash Burn Situation

Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why

Zacks

10 months ago

Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why

Los Angeles County Awards 5 Year Contract to Genasys for Evacuation Management Solution

GlobeNewswire

10 months ago

Los Angeles County Awards 5 Year Contract to Genasys for Evacuation Management Solution

Nyxoah Announces 2024 Strategic Priorities

GlobeNewswire

10 months ago

Nyxoah Announces 2024 Strategic Priorities

Analysts Expect comScore, Inc. (NASDAQ:SCOR) To Breakeven Soon

Simply Wall St.

10 months ago

Analysts Expect comScore, Inc. (NASDAQ:SCOR) To Breakeven Soon

GlobeNewswire

10 months ago

Powell Industries Announces Date and Conference Call for Fiscal 2024 First Quarter Results

Babcock & Wilcox Enterprises, Inc. (NYSE:BW) is largely controlled by institutional shareholders who own 52% of the company

Simply Wall St.

10 months ago

Babcock & Wilcox Enterprises, Inc. (NYSE:BW) is largely controlled by institutional shareholders who own 52% of the company

QuickLogic (QUIK) Laps the Stock Market: Here's Why

Zacks

10 months ago

QuickLogic (QUIK) Laps the Stock Market: Here's Why

GeneDx Announces Preliminary 2023 Financial Results

GlobeNewswire

10 months ago

GeneDx Announces Preliminary 2023 Financial Results

Blackstone Credit Closed-End Funds Announce Trustee and Officer Changes

PR Newswire

a year ago

Blackstone Credit Closed-End Funds Announce Trustee and Officer Changes

Bluebird’s Plans to Win in Sickle Cell Come Into Focus

The Wall Street Journal

a year ago

Bluebird’s Plans to Win in Sickle Cell Come Into Focus

Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones

GlobeNewswire

a year ago

Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones

Is Now The Time To Look At Buying Tuniu Corporation (NASDAQ:TOUR)?

Simply Wall St.

a year ago

Is Now The Time To Look At Buying Tuniu Corporation (NASDAQ:TOUR)?

Steven Cohen's Point72 Asset Management Acquires New Stake in Syros Pharmaceuticals

GuruFocus.com

a year ago

Steven Cohen's Point72 Asset Management Acquires New Stake in Syros Pharmaceuticals

NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

News Direct

a year ago

NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

NKGen Biotech, Inc. Announces Dosing of First Patient in its Phase 1/2a Trial with Autologous NK Cell Product, SNK01, for the Treatment of Moderate Alzheimer’s Disease

GlobeNewswire

a year ago

NKGen Biotech, Inc. Announces Dosing of First Patient in its Phase 1/2a Trial with Autologous NK Cell Product, SNK01, for the Treatment of Moderate Alzheimer’s Disease

MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army

GlobeNewswire

a year ago

MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army

NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease

GlobeNewswire

a year ago

NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

The Fly

a year ago

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

ZeroFox Achieves Outstanding Recognition in G2's Winter 2024 Report, Securing Multiple Badges in Key Cybersecurity Categories

GlobeNewswire

a year ago

ZeroFox Achieves Outstanding Recognition in G2's Winter 2024 Report, Securing Multiple Badges in Key Cybersecurity Categories

Willdan Group, Inc. (NASDAQ:WLDN) is favoured by institutional owners who hold 64% of the company

Simply Wall St.

a year ago

Willdan Group, Inc. (NASDAQ:WLDN) is favoured by institutional owners who hold 64% of the company

Kodiak Gas Services, Inc. to Acquire CSI Compressco LP in an $854 Million All-Equity Transaction

PR Newswire

a year ago

Kodiak Gas Services, Inc. to Acquire CSI Compressco LP in an $854 Million All-Equity Transaction

SP Plus Corporation Upgrades Parking Services on the University of Akron Campus

GlobeNewswire

a year ago

SP Plus Corporation Upgrades Parking Services on the University of Akron Campus

Why Duluth Holdings Inc. (NASDAQ:DLTH) Could Be Worth Watching

Simply Wall St.

a year ago

Why Duluth Holdings Inc. (NASDAQ:DLTH) Could Be Worth Watching

Wall Street Analysts Think WalkMe (WKME) Could Surge 42.87%: Read This Before Placing a Bet

Zacks

a year ago

Wall Street Analysts Think WalkMe (WKME) Could Surge 42.87%: Read This Before Placing a Bet

Levicept Appoints Eliot Forster as CEO

GlobeNewswire

a year ago

Levicept Appoints Eliot Forster as CEO

Cool Company Ltd.: 2023 AGM Results Notification

Business Wire

a year ago

Cool Company Ltd.: 2023 AGM Results Notification

Capital Allocation Trends At ACCO Brands (NYSE:ACCO) Aren't Ideal

Simply Wall St.

a year ago

Capital Allocation Trends At ACCO Brands (NYSE:ACCO) Aren't Ideal

Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC

PR Newswire

a year ago

Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC

Wrap Technologies, Inc. Bolsters BolaWrap® 150 Deployments, Promoting Safer Communities Nationwide

GlobeNewswire

a year ago

Wrap Technologies, Inc. Bolsters BolaWrap® 150 Deployments, Promoting Safer Communities Nationwide

Zentek Announces Update on the Albany Graphite Project

ACCESSWIRE

a year ago

Zentek Announces Update on the Albany Graphite Project

Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Zacks Value Trader Highlights: Citizens Community Bancorp, FinWise Bancorp, First Bank, NorthEast Community Bancorp and OP Bancor

Zacks

a year ago

Zacks Value Trader Highlights: Citizens Community Bancorp, FinWise Bancorp, First Bank, NorthEast Community Bancorp and OP Bancor

Cybin to Host CYB003 Topline Depression Study Review and R&D Briefing on November 30, 2023, in New York City

Business Wire

a year ago

Cybin to Host CYB003 Topline Depression Study Review and R&D Briefing on November 30, 2023, in New York City

Capital Allocation Trends At Computer Programs and Systems (NASDAQ:CPSI) Aren't Ideal

Simply Wall St.

a year ago

Capital Allocation Trends At Computer Programs and Systems (NASDAQ:CPSI) Aren't Ideal

5 Cheap Strong Buy Bank Stocks in 2023

Zacks

a year ago

5 Cheap Strong Buy Bank Stocks in 2023

NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights

GlobeNewswire

a year ago

NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights

Lument Finance Trust Reports Third Quarter Results

PR Newswire

a year ago

Lument Finance Trust Reports Third Quarter Results

PHH Mortgage Announces New Subservicing Agreement With Zillow Home Loans

GlobeNewswire

a year ago

PHH Mortgage Announces New Subservicing Agreement With Zillow Home Loans

MEGA MATRIX CORP. Reports Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

MEGA MATRIX CORP. Reports Third Quarter 2023 Financial Results

Investors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price Jump

Simply Wall St.

a year ago

Investors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price Jump

Even With A 27% Surge, Cautious Investors Are Not Rewarding Nutex Health Inc.'s (NASDAQ:NUTX) Performance Completely

Simply Wall St.

a year ago

Even With A 27% Surge, Cautious Investors Are Not Rewarding Nutex Health Inc.'s (NASDAQ:NUTX) Performance Completely

Stonegate Capital Partners Updates Coverage On Aemetis, Inc. (AMTX) Q3 2023

Newsfile

a year ago

Stonegate Capital Partners Updates Coverage On Aemetis, Inc. (AMTX) Q3 2023

Computer Programs and Systems, Inc. (NASDAQ:CPSI) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Computer Programs and Systems, Inc. (NASDAQ:CPSI) Q3 2023 Earnings Call Transcript

Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results

Business Wire

a year ago

Vistagen Provides Corporate Update and Reports Fiscal 2024 Second Quarter Financial Results

Associated Press Finance

a year ago

Digital Turbine: Fiscal Q2 Earnings Snapshot

Lument Finance Trust Announces Quarter-End Earnings Release and Investor Call Dates

PR Newswire

a year ago

Lument Finance Trust Announces Quarter-End Earnings Release and Investor Call Dates

Digital Turbine Reports Fiscal 2024 Second Quarter Financial Results

PR Newswire

a year ago

Digital Turbine Reports Fiscal 2024 Second Quarter Financial Results

GlycoMimetics, Inc. (NASDAQ:GLYC) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

GlycoMimetics, Inc. (NASDAQ:GLYC) Q3 2023 Earnings Call Transcript

Should Value Investors Buy Medallion Financial (MFIN) Stock?

Zacks

a year ago

Should Value Investors Buy Medallion Financial (MFIN) Stock?

Share on Social Networks: